Finance

Lists
000520:KRX
Samil Pharmaceutical Co Ltd
8 140,00 KRW
-1,09%
(-90,00) 1D
20 ოქტ, 09:44:24 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 000520...
Open
8 170 KRW
High
8 240 KRW
Low
8 040 KRW
Mkt. cap
176,35 მლრ.
Avg. vol.
89,41 ათ.
Volume
8,18 ათ.
52-wk high
12 860 KRW
52-wk low
5 500 KRW
EPS
-1 768 KRW
Shares outstanding
21,69 მლნ.
No. of employees
583
Open
8 170 KRW
High
8 240 KRW
Low
8 040 KRW
Mkt. cap
176,35 მლრ.
Avg. vol.
89,41 ათ.
Volume
8,18 ათ.
52-wk high
12 860 KRW
52-wk low
5 500 KRW
EPS
-1 768 KRW
Shares outstanding
21,69 მლნ.
No. of employees
583
News stories
From web sources and news partners
About Samil Pharmaceutical Co Ltd
CEOSeung-Bum Huh
Employees583
Founded1947
Headquarters-
SectorPharmaceutical industry
Websitesamil-pharm.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
51,18 მლრდ.
53,00 მლრდ.
52,55 მლრდ.
50,60 მლრდ.
Cost of goods sold
32,69 მლრდ.
33,56 მლრდ.
35,46 მლრდ.
31,67 მლრდ.
Cost of revenue
32,69 მლრდ.
33,56 მლრდ.
35,46 მლრდ.
31,67 მლრდ.
Research and development expenses
2,12 მლრდ.
1,95 მლრდ.
1,54 მლრდ.
1,11 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18,72 მლრდ.
23,40 მლრდ.
21,31 მლრდ.
21,62 მლრდ.
Operating expense
23,65 მლრდ.
29,72 მლრდ.
25,47 მლრდ.
25,27 მლრდ.
Total operating expenses
56,34 მლრდ.
63,27 მლრდ.
60,93 მლრდ.
56,94 მლრდ.
Operating income
-5,17 მლრდ.
-10,27 მლრდ.
-8,39 მლრდ.
-6,34 მლრდ.
Other non operating income
-150,57 მლნ.
-86,20 მლნ.
61,42 მლნ.
265,18 მლნ.
EBT including unusual items
-7,70 მლრდ.
-12,75 მლრდ.
-10,62 მლრდ.
-8,50 მლრდ.
EBT excluding unusual items
-7,70 მლრდ.
-12,52 მლრდ.
-10,61 მლრდ.
-8,27 მლრდ.
Income tax expense
225,00 მლნ.
-1,59 მლრდ.
209,00 მლნ.
-805,73 მლნ.
Effective tax rate
-2,92%
12,45%
-1,97%
9,48%
Other operating expenses
58,40 მლნ.
224,61 მლნ.
127,20 მლნ.
242,60 მლნ.
Net income
-7,93 მლრდ.
-11,16 მლრდ.
-10,83 მლრდ.
-7,69 მლრდ.
Net profit margin
-15,49%
-21,06%
-20,62%
-15,20%
Earnings per share
-
-
-
-
Interest and investment income
12,05 მლნ.
11,10 მლნ.
10,33 მლნ.
13,76 მლნ.
Interest expense
-2,29 მლრდ.
-2,17 მლრდ.
-2,14 მლრდ.
-2,23 მლრდ.
Net interest expenses
-2,27 მლრდ.
-2,16 მლრდ.
-2,13 მლრდ.
-2,22 მლრდ.
Depreciation and amortization charges
2,07 მლრდ.
2,17 მლრდ.
2,12 მლრდ.
2,01 მლრდ.
EBITDA
-1,91 მლრდ.
-7,97 მლრდ.
-4,92 მლრდ.
-2,95 მლრდ.
Gain or loss from assets sale
-
-1,14 მლნ.
18,43 მლნ.
228,07 მლნ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები